The association between the transradial approach for percutaneous coronary interventions and bleeding

Journal of Invasive Cardiology

Volumn 21, Issue 8 SUPPL.A, 2009, Pages 21-24

  Vavalle, John P ^a   Rao, Sunil V ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD TRANSFUSION; DISEASE ASSOCIATION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RADIAL ARTERY; SHORT SURVEY; SURVIVAL; TREATMENT OUTCOME; VASCULAR ACCESS;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; HEMORRHAGE; HUMANS; PREVALENCE; RADIAL ARTERY;

EID: 71549117672     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (31)

1. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009;157 (1) :132-140.
2. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989;16 (1) :3-7.
3. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the national cardiovascular data registry. JACC Cardiovasc Interv 2008;1:379-386.
4. Singh M, Rihal CS, Gersh BJ, et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention. a single-institution experience. Circulation 2007;115:2835-2841.
5. Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary interventionsincidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009;10:88-93.
6. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007;69:961-966.
7. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-1369.
8. Manoukian, SV, F Feit, R Mehran et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes. an analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-1368.
9. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-1206.
10. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935.
11. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial. JAMA 2003;289:853-863.
12. Bertrand OF, Larose E, Rodes-Cabau J, et al. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. Am Heart J 2009;157:164-169.
13. Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507-514.
14. Chinese Coordinating Center of OASIS Registry. The clinical characteristics of acute coronary syndrome in China. Zhonghua Nei Ke Za Zhi 2003;42:697-700.
15. Prabhakaran D, Yusuf S, Mehta S, et al. Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome. results of the OASIS registry 1 and 2. Indian Heart J 2005;57:217-225.
16. [No authors listed]. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 1999;353:429-438.
17. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New Engl J Med 2001;345:494-502.
18. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-782.
19. Ellis SG, Bhatt D, Kapadia S, et al. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:541-545.
20. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications. implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:196-202.
21. Garrett PD, Eckart RE, Bauch TD, et al. Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv 2005;65:205-207.
22. Mann JT 3rd, Cubeddu MG, Schneider JE, Arrowood M. Right radial access for PTCA. A Prospective Study Demonstrates Reduced Complications and Hospital Charges. J Invasive Cardiol 1996;8 (Suppl D) :40D-44D.
23. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The access study. J Am Coll Cardiol 1997;29:1269-1275.
24. Benit E, Missault L, Eeman T, et al. Brachial, radial, or femoral approach for elective Palmaz-Schatz stent implantation. a randomized comparison. Cathet Cardiovasc Diagn 1997;41:124-130.
25. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction. results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv 2003;59:26-33.
26. Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial. Am Heart J 2005;150:543-549.
27. Brasselet C, Tassan S, Nazeyrollas P, et al. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart 2007;93:1556-1561.
28. Valsecchi O, Musumeci G, Vassileva A, et al. Safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction. Ital Heart 2003;4:329-334.
29. Pristipino C, Trani C, Nazzaro MS, et al. Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterization: results from the PREVAIL study. Heart 2009;95:476-482.
30. Chase AJ, Fretz EB, Warburton WP, et al. Association of the arterial access site at angioplasty with transfusion and mortality. the M. O. R. T. A. L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-1025.
31. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-356.